1. Home
  2. CTNT vs SILO Comparison

CTNT vs SILO Comparison

Compare CTNT & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$2.69

Market Cap

6.4M

Sector

N/A

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.39

Market Cap

7.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
SILO
Founded
2016
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.2M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
CTNT
SILO
Price
$2.69
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
168.3M
1.5M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
57.98
EPS
N/A
N/A
Revenue
$1,288,536.00
$72,102.00
Revenue This Year
$42.49
$1.86
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$0.22
52 Week High
$4.21
$1.13

Technical Indicators

Market Signals
Indicator
CTNT
SILO
Relative Strength Index (RSI) 64.10 44.15
Support Level $1.48 $0.40
Resistance Level $4.21 $0.47
Average True Range (ATR) 0.34 0.04
MACD 0.19 -0.01
Stochastic Oscillator 64.30 6.48

Price Performance

Historical Comparison
CTNT
SILO

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Share on Social Networks: